#EULAR2024 21-24% of #APS patients have #metabolic syndrome Also ⬆️ rates if atherosclerotic plaque progression in pts with #AntiPhospholipidSyndrome #CVD #IHD #ASCVD By @MariaTektonidou https://t.co/EZsxJE7YJa